HepZero:Heparin Free Dialysis With Evodial
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 265 participants.
Also called NCT01318486
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 265 participants
- Registry
-
NCT01318486
-
- Other papers using this trial's data
- Results of the HepZero study comparing heparin-grafted membrane and standard care show that heparin-grafted dialyzer is safe and easy to use for heparin-free dialysis
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Belgium, Canada, France, Netherlands, Poland, Spain, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01318486. Randomized; no masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2013-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- HepZero:Heparin Free Dialysis With Evodial
- Condition
- Chronic Kidney Disease
- Condition
- Patients Requiring Heparin Free Dialysis Treatments
- Intervention (Other)
- Heparin free dialysis technique
- Intervention (Device)
- Evodial
- Lead sponsor
- Vantive Health LLC
- Collaborator
- Statistical Analysis : CIC CHU Brabois Nancy
- Collaborator
- Gambro Lundia AB
- Collaborator
- Baxter Healthcare Corporation
Record details
- Record id
cardio:ct-nct01318486- Content hash
ebe941c3dca131fe605ab11b4a57c4097885cfeed22b0eb1ef89f9103075cf70